Last reviewed · How we verify

NCT05746650: GH-MTJ

Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury

Recruiting now NA Last updated 24 September 2025
What this trial tests

NA trial testing Electrical stimulation in Muscle Injury in 40 participants. Currently enrolling.

Timeline
24 February 2023
Primary endpoint
1 June 2027
1 September 2027

Quick facts

Lead sponsorBispebjerg Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposebasic science
Enrollment40
Start date24 February 2023
Primary completion1 June 2027
Estimated completion1 September 2027
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Bispebjerg Hospital

Who can join

Adults 18 to 35, any sex, with Muscle Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a 2-week human study where 40 patients who are scheduled to undergo reconstructive knee surgery are randomized to administration of GH or placebo following or without neuromuscular electrical stimulation of hamstring muscles.The overall aim is to determine, the role of muscle connective tissue protein synthesis in muscle injury and repair.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Electrical stimulation

Trials testing the same drug.

Other recruiting trials for Muscle Injury

Currently open trials in the same condition.

Other Bispebjerg Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05746650.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing